Prof. Ilan Bruchim

Prof. Ilan Bruchim is the head of the Gynecologic Oncology Clinic and Women’s Department at Hillel Yaffe Medical Center. He is also a former chairman of the Israeli Society of Gynecologic Oncology. Prof. Bruchim specializes in women’s health, gynecologic oncology, and benign and malignant diseases of the female reproductive system. He performs various types of surgeries, including gynecologic and oncologic surgeries, laparoscopic surgeries, robot-assisted surgeries, hysterectomies using various techniques, oophorectomies, salpingectomies, and many more. Prof. Bruchim offers comprehensive consultations and supports patients at every stage. His clinics collaborate with active insurance companies in Israel as well as with general health funds and Maccabi.

Prof. Bruchim performs gynecologic surgeries related to the reproductive organs, uterus, cervix, ovaries, and fallopian tubes. A significant portion of these surgeries is conducted using minimally invasive surgical procedures, without the need for abdominal incisions.

During these surgeries, a small camera is used, which penetrates the abdominal cavity and transmits the image to a video screen, allowing for the observation of pelvic and abdominal organs and the performance of surgery.

Prof. Bruchim also performs various other surgeries, including single-port laparoscopic hysterectomy. This surgery has many advantages, such as rapid healing, less pain, and significantly better cosmetic outcomes compared to open surgery.

As part of his practice, Prof. Bruchim also conducts colposcopy, which is a diagnostic examination of the cervix, vagina, and vulva using specialized optical equipment called a colposcope. The main goal of colposcopy is the early detection of cervical cancer by identifying precancerous changes and providing treatment.

Prof. Bruchim also offers advice and treatment to women with a family history of breast and ovarian cancer or carriers of mutations in the BRCA1/2 genes. Additionally, he performs assessments of the risk and makes decisions regarding the removal of the uterus and ovaries as preventive measures in cases of high risk of developing cancer.